Vor Biopharma Inc. monthly returns
Vor Biopharma Inc. has averaged 8.20% per month, positive in 41% of months. Month-by-month returns for Vor Biopharma Inc. (VOR) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Vor Biopharma Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -0.3% | |
| Sep 2026 | -15.1% | |
| Aug 2026 | +6.3% | |
| Jul 2026 | +14.9% | |
| Jun 2026 | +23.0% | |
| May 2026 | +4.5% | |
| Apr 2026 | -19.7% | |
| Mar 2026 | +15.5% | |
| Feb 2026 | +18.8% | |
| Jan 2026 | -0.6% | |
| Dec 2025 | +57.0% | |
| Nov 2025 | -65.5% | |
| Oct 2025 | -50.5% | |
| Sep 2025 | +23.7% | |
| Aug 2025 | -4.8% | |
| Jul 2025 | +27.8% | |
| Jun 2025 | +710.0% | |
| May 2025 | -70.5% | |
| Apr 2025 | -5.4% | |
| Mar 2025 | -33.5% | |
| Feb 2025 | -23.9% | |
| Jan 2025 | +27.9% | |
| Dec 2024 | +33.4% | |
| Nov 2024 | -1.0% | |
| Oct 2024 | +20.0% | |
| Sep 2024 | -19.9% | |
| Aug 2024 | -5.9% | |
| Jul 2024 | -7.1% | |
| Jun 2024 | -25.9% | |
| May 2024 | -21.5% | |
| Apr 2024 | -27.4% | |
| Mar 2024 | +3.0% | |
| Feb 2024 | +0.0% | |
| Jan 2024 | +2.2% | |
| Dec 2023 | +21.6% | |
| Nov 2023 | +1.1% | |
| Oct 2023 | -13.7% | |
| Sep 2023 | -15.2% | |
| Aug 2023 | -17.2% | |
| Jul 2023 | -2.3% | |
| Jun 2023 | -34.3% | |
| May 2023 | +5.6% | |
| Apr 2023 | -17.3% | |
| Mar 2023 | -3.6% | |
| Feb 2023 | +5.9% | |
| Jan 2023 | -20.8% | |
| Dec 2022 | +44.6% | |
| Nov 2022 | -4.4% | |
| Oct 2022 | +20.9% | |
| Sep 2022 | -22.4% | |
| Aug 2022 | +11.3% | |
| Jul 2022 | -7.2% | |
| Jun 2022 | +18.1% | |
| May 2022 | -26.5% | |
| Apr 2022 | -5.1% | |
| Mar 2022 | -33.1% | |
| Feb 2022 | +9.5% | |
| Jan 2022 | -29.0% | |
| Dec 2021 | +0.7% | |
| Nov 2021 | -26.6% | |
| Oct 2021 | +0.3% | |
| Sep 2021 | +6.7% | |
| Aug 2021 | +17.3% | |
| Jul 2021 | -32.9% | |
| Jun 2021 | -11.6% | |
| May 2021 | -25.1% | |
| Apr 2021 | -34.6% | |
| Mar 2021 | -4.1% |
Monthly total return (since Jan 2022)#
Vor Biopharma Inc. returns by calendar month#
Every month of every year since 2022, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -0.26% — 3rd of 5 Octobers since 2022 at the last close; the average October returned -5.8%.
| Month | −710%0+710% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -4.0% | -0.6% | 40% | +27.9% 2025 | -29.0% 2022 | |
| Feb | +2.0% | +5.9% | 60% | +18.8% 2026 | -23.9% 2025 | |
| Mar | -10.3% | -3.6% | 40% | +15.5% 2026 | -33.5% 2025 | |
| Apr | -15.0% | -17.3% | 0% | -5.1% 2022 | -27.4% 2024 | |
| May | -21.7% | -21.5% | 40% | +5.6% 2023 | -70.5% 2025 | |
| Jun | +138.2% | +18.1% | 60% | +710.0% 2025 | -34.3% 2023 | |
| Jul | +5.2% | -2.3% | 40% | +27.8% 2025 | -7.2% 2022 | |
| Aug | -2.1% | -4.8% | 40% | +11.3% 2022 | -17.2% 2023 | |
| Sep | -9.8% | -15.2% | 20% | +23.7% 2025 | -22.4% 2022 | |
| Oct | -5.8% | +3.2% | 50% | +20.9% 2022 | -50.5% 2025 | |
| Nov | -17.4% | -2.7% | 25% | +1.1% 2023 | -65.5% 2025 | |
| Dec | +39.2% | +39.0% | 100% | +57.0% 2025 | +21.6% 2023 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from VOR's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Vor Biopharma Inc.'s average monthly return?
- Vor Biopharma Inc. (VOR) has averaged about 8.20% per month, positive in roughly 41% of months. The best month was Jun 2025 (+710.0%) and the worst was May 2025 (-70.5%).